Illumina, Inc. has announced that it is collaborating with the Wellcome Trust Sanger Institute (WTSI) and the Wellcome Trust Case-Control Consortium (WT-CCC) on the design of a custom Sentrix® ...

The previous Illumina 450K Methylation BeadChip array revolutionized the field of DNA methylation analysis, enabling for the first time comprehensive genome-wide DNA methylation analysis in large ...

The Illumina® Expression BeadChip® arrays are the preferred system for array-based gene expression studies because of their low input requirement, high sensitivity, low cost and high throughput.

Illumina, Inc. today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide common and ...

Illumina, Inc. today unveiled its new HumanOmniExpress+ Custom BeadChip (OmniExpress+), an enhancement to the recently announced OmniExpress BeadChip that allows for the addition of up to 200,000 ...

A Washington court ruled against Illumina in a patent lawsuit Thursday, finding that the sequencing giant infringed on Syntrix Biosystems' intellectual property and ordering the company to pay out ...

Blood Test (ENA IgG BeadChip) for Diagnosis of Autoimmune Disorders. On May 31, ... The test is designed for use with the company's Array Imaging System 400 (AIS400).

The suit covers Illumina's BeadChip array, used in DNA and RNA analysis, which the court deemed to have infringed on Syntrix's similar technology. The $96 million figure is based on a royalty rate ...